search
Back to results

Analgetic Effect of Preoperative Pregabalin in Patients Undergoing Nephrectomy (PregabaNeph)

Primary Purpose

Postoperative Pain

Status
Completed
Phase
Phase 3
Locations
Austria
Study Type
Interventional
Intervention
Pregabalin
Placebo
Sponsored by
Medical University of Graz
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Postoperative Pain

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • patients undergoing elective nephrectomy

Exclusion Criteria:

  • contraindication against pregabalin
  • creatinine > 2.0 mg/dl
  • GGT >165, AST >105, ALT >135
  • peptic Ulcus
  • haemorrhagic diathesis
  • angina pectoris, myocardial infarction
  • stroke
  • bronchial asthma
  • opioid abuse

Sites / Locations

  • Medical University of Graz

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Active Comparator

Arm Label

Placebo

Pregabalin group

Arm Description

Placebo

Receiving 300mg pregabalin preoperative

Outcomes

Primary Outcome Measures

postoperative opioid consumption

Secondary Outcome Measures

Full Information

First Posted
August 11, 2009
Last Updated
May 26, 2011
Sponsor
Medical University of Graz
search

1. Study Identification

Unique Protocol Identification Number
NCT00957177
Brief Title
Analgetic Effect of Preoperative Pregabalin in Patients Undergoing Nephrectomy
Acronym
PregabaNeph
Official Title
Effect of Preoperative Pregabalin Administration on the Postoperative Opioid Consumption in Patients Undergoing Nephrectomy
Study Type
Interventional

2. Study Status

Record Verification Date
May 2011
Overall Recruitment Status
Completed
Study Start Date
April 2009 (undefined)
Primary Completion Date
December 2010 (Actual)
Study Completion Date
December 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Medical University of Graz

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Pregabalin 300mg or placebo are administered 1 hour preoperatively in patients undergoing elective nephrectomy. Postoperatively, patients receive a patient controlled analgesia device for self delivering opioids. Morphine consumption in the first 48 hours is documented. Hyperalgesia is measured by von-Frey-Filaments.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Placebo
Arm Title
Pregabalin group
Arm Type
Active Comparator
Arm Description
Receiving 300mg pregabalin preoperative
Intervention Type
Drug
Intervention Name(s)
Pregabalin
Other Intervention Name(s)
Lyrica
Intervention Description
300mg pregabalin orally 1 hour before operation
Intervention Type
Drug
Intervention Name(s)
Placebo
Other Intervention Name(s)
Control
Intervention Description
Placebo
Primary Outcome Measure Information:
Title
postoperative opioid consumption
Time Frame
48 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: patients undergoing elective nephrectomy Exclusion Criteria: contraindication against pregabalin creatinine > 2.0 mg/dl GGT >165, AST >105, ALT >135 peptic Ulcus haemorrhagic diathesis angina pectoris, myocardial infarction stroke bronchial asthma opioid abuse
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andreas Sandner-Kiesling, MD
Organizational Affiliation
Medical University of Graz
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Helmar Bornemann-Cimenti, MD, DSc
Organizational Affiliation
Graz Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical University of Graz
City
Graz
ZIP/Postal Code
8036
Country
Austria

12. IPD Sharing Statement

Links:
URL
http://www.medunigraz.at
Description
Medical University of Graz

Learn more about this trial

Analgetic Effect of Preoperative Pregabalin in Patients Undergoing Nephrectomy

We'll reach out to this number within 24 hrs